His Existence Questioned

The Jan. 8, 1996, issue of The Scientist contains a letter that seems to say, if I understand it correctly, that I do not exist [G.H. Scherr, page 12]. The letter concerns the Annals of Improbable Research (AIR) and the publication I used to edit, the Journal of Irreproducible Results (JIR). I was especially surprised and delighted to read that "neither Abrahams nor the AIR were ever associated with the Ig Nobel Prize." In 1991, I created and hosted the (now) annual Ig Nobel Prize ceremonies,

Written byMarc Abrahams
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I was especially surprised and delighted to read that "neither Abrahams nor the AIR were ever associated with the Ig Nobel Prize." In 1991, I created and hosted the (now) annual Ig Nobel Prize ceremonies, which were held at the Massachusetts Institute of Technology for the first four years and at Harvard University this past October.

Scherr also says that he was "the editor" of JIR "during the entire period" of JIR's existence. 'Taint so on either count. A look at the old JIR mastheads (available in any fine library) shows that Alexander Kohn and Harry Lipkin founded JIR in 1955 and were its coeditors until 1964. Alex was JIR's sole editor from 1964 to 1989. I served in that role from 1990 to 1994. Scherr's association with JIR didn't begin until 1964, when he bought the trademark and became the "publisher"; in 1989, he sold the journal to another ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies